Author: Work & Theory

<![CDATA[Medicare’s $10 billion wake-up call: Wound care is more than numbers — why primary care physicians must step up in 2026]]>

Continue reading →

<![CDATA[RPM in 2026: What conditions to treat? Many, many of them]]>

Continue reading →

<![CDATA[Best of 2025: Vaccination expert panel takes on misinformation]]>

Continue reading →

French Customs Finds 25% of Shein Parcels Non-Compliant

A quarter of Shein packages entering France fail safety or labeling checks, raising compliance concerns with EU standards, the French government said. Continue reading →

UK Retail’s Net-Zero Math Won’t Work Without Government Muscle, BRC Warns

The trade organization’s five-year review finds progress in stores but stalled supply-chain emissions leave 2040 target out of reach. Continue reading →

Rival Railroads Slam UP-NS Merger Application, Citing Incomplete Data

Class I railroads BNSF, CPKC, CN and CSX argue the filing violates STB merger rules and leaves key competition and market impacts unanswered. Continue reading →

US East, Gulf coast ports expanding intermodal access, vessel capacity

While some gateways are expanding their intermodal access to vie for discretionary cargo destined for inland locations, others are moving full speed ahead with capacity expansions that will allow them to handle more and larger ships. Continue reading →

Hong Kong to launch digital cargo tracking, data exchange network

The use of real-time cargo status data is expected to make trade finance more efficient, reducing credit costs and processing and payment times, the Hong Kong government said. Continue reading →

UP-NS deal could benefit some shippers, while others face longer transits

While Union Pacific plans to spend hundreds of millions of dollars to make a combined railroad run smoothly, there are locations where service could degrade should the merger be approved by federal regulators. Continue reading →

How Endogenous Tagging is Reshaping Protein Analysis

Understanding how proteins behave inside living cells is essential for modern drug discovery. Yet many widely used approaches, particularly plasmid overexpression systems and primary antibody–dependent assays, can alter or obscure the biology researchers aim to understand. Overexpression may...